The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. Russo D, Spina A, Portella L, Bello AM, et al. PLoS One 2024;19:e0314735.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Russo D, Spina A, Portella L, Bello AM, et al. The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. PLoS One 2024;19:e0314735.
PMID: 39700131